Ovacome Summer 2014
Ovacome Summer 2014
Ovacome Summer 2014
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Photography: Daily Echo, Bournemouth<br />
news<br />
Singing to recovery<br />
Gareth Malone, the preppy choirmaster credited with reigniting our interest in<br />
choral singing through his BBC Two series The Choir, would be proud. For word<br />
is getting around about how uplifting being part of a singing group can be and the<br />
benefits are numerous when dealing with illness.<br />
Rising Voices - a community choir for people affected by<br />
cancer in Dorset, Hampshire and Wiltshire - has found in<br />
a study that members have benefited from being part of a<br />
mutually empathetic community, in which they were not<br />
treated as victims.<br />
Altogether Rising Voices: Noëline Young (fourth from left, front row).<br />
As well as getting enjoyment from singing as a group,<br />
members liked the social interaction at weekly rehearsals and<br />
the travel to events, which could be anywhere from a local<br />
shopping centre or Women’s Institute meeting to a twinned<br />
event in Cherbourg.<br />
Concentrated chemo<br />
A<br />
decision on whether to<br />
progress with a new method of<br />
chemotherapy for treating ovarian cancer<br />
could be made soon.<br />
PETROC is a study of the use of<br />
chemotherapy that is given into the<br />
peritoneal space (IP) for ovarian cancer,<br />
rather than into a vein (IV). This<br />
increases the concentration of the drug<br />
around the cancer and can increase its<br />
effectiveness. The study is for patients<br />
who need to complete their treatment<br />
after primary chemotherapy for three<br />
cycles and a successful interval operation.<br />
This technique was new to the UK<br />
while it had been tested previously in<br />
the USA. The early studies had a lot of<br />
problems with toxicity which delayed<br />
acceptance in the UK. However,<br />
medical staff have learnt how to give<br />
the treatment much more safely, and<br />
UK centres have been trained so that<br />
after the first 150 patients there was<br />
no difference in toxicity between the<br />
Carboplatin and Paclitaxel given in the<br />
IP arm or the control IV arm.<br />
There was a third arm in the study using<br />
IP Cisplatin instead of the Carboplatin,<br />
however the independent data<br />
monitoring committee recommended<br />
that this be stopped as it was no more<br />
effective and more toxic.<br />
Member and <strong>Ovacome</strong> trustee Noëline Young says that the<br />
established associations between music and health, both<br />
physical and spiritual, have been well documented and<br />
highlighted in a report by Cardiff University.*<br />
“Participation in music making has been shown to improve<br />
well being and music has the power to communicate with<br />
individuals at times of difficulty. This formed the background<br />
to the establishment of our survivors’ choir, Rising Voices,”<br />
says Noëline, an ovarian cancer survivor herself.<br />
“The intention was to encourage participation in singing<br />
to boost confidence and social interaction and promote<br />
wellbeing, as an aid to recovery from cancer.”<br />
The choir has been supported by a start-up grant from<br />
Macmillan Cancer Support and Dorset Cancer Network, but<br />
longer term it plans to be self-sufficient, supported through<br />
voluntary donations by members, friends, donations and<br />
money raised from public performances.<br />
If you are interested in joining Rising Voices, it rehearses<br />
weekly at St John’s Church in Parkstone, Poole.<br />
e-mail admin@risingvoices.org.uk or phone 07500 676083.<br />
*Gale NS, Enright S, Reagon C, Lewis I, van Deursen R.<br />
A pilot investigation of quality of life and lung function following<br />
choral singing in cancer survivors and their carers. Cancer,<br />
2012; 6:261<br />
The study has now been resubmitted to<br />
Cancer Research UK with the planned<br />
interim analysis to allow the number<br />
of centres giving IP treatment in the<br />
UK to increase from nine to 28 and<br />
to include a further 630 patients in<br />
the trial, to prove whether it increases<br />
survival.<br />
Dr Sean Kehoe, a gynae surgeon.<br />
has reviewed the medical stories on<br />
page 4 and 5<br />
4 Phone <strong>Ovacome</strong>’s nurse led support line on 0845 371 0554 it together